Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Apyx Medical (APYX) Other Non-Current Liabilities (2016 - 2025)

Apyx Medical (APYX) has disclosed Other Non-Current Liabilities for 14 consecutive years, with $347000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Other Non-Current Liabilities rose 33.98% year-over-year to $347000.0, compared with a TTM value of $347000.0 through Dec 2025, up 33.98%, and an annual FY2025 reading of $347000.0, up 33.98% over the prior year.
  • Other Non-Current Liabilities was $347000.0 for Q4 2025 at Apyx Medical, up from $293000.0 in the prior quarter.
  • Across five years, Other Non-Current Liabilities topped out at $347000.0 in Q4 2025 and bottomed at $133000.0 in Q3 2022.
  • Average Other Non-Current Liabilities over 5 years is $200100.0, with a median of $185000.0 recorded in 2023.
  • The sharpest move saw Other Non-Current Liabilities crashed 81.05% in 2021, then surged 52.08% in 2025.
  • Year by year, Other Non-Current Liabilities stood at $166000.0 in 2021, then grew by 9.04% to $181000.0 in 2022, then rose by 9.39% to $198000.0 in 2023, then skyrocketed by 30.81% to $259000.0 in 2024, then skyrocketed by 33.98% to $347000.0 in 2025.
  • Business Quant data shows Other Non-Current Liabilities for APYX at $347000.0 in Q4 2025, $293000.0 in Q3 2025, and $292000.0 in Q2 2025.